Friday, July 4, 2025 7/4/2025

Role of the AR-ErbB3-Nrdp1 axis in mediating prostate cancer health disparities

Award Number: R15CA202757
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2016
PERIOD OF PERFORMANCE END DATE: 03/31/2021

Group Awards By:

View Award Description

Role of the AR-ErbB3-Nrdp1 axis in mediating prostate cancer health disparities - DESCRIPTION (provided by applicant): The proposed research project falls into the category of Basic and Applied Biomedical Research. The overall goal of the project is to better understand the role of genetic factors in mediating accelerated prostate cancer (CaP) progression in African American (AA) men. Specifically, we will elucidate the mechanisms which cause decreased Nrdp1 levels and subsequent dysfunction of the AR-ErbB3-Nrdp1 signaling axis in AA CaP cells. We will determine the stage of disease at which dysfunction occurs, and confirm that this dysfunction causes accelerated CaP in AA patients. Understanding the causes of reduced Nrdp1 levels and dysfunction of the AR- ErbB3-Nrdp1 signaling axis in AA CaP patients will allow for the development of therapeutics to restore Nrdp1 levels and AR-ErbB3-Nrdp1 signaling axis function. Assessment of Nrdp1, AR, and ErbB3 at different disease stages will potentially allow for the development of these molecules as prognostic biomarkers. Development of improved biomarkers and therapeutics is needed to help address CaP health disparities. More than 75% of CNUCOP students are from minority populations. Historically, relatively few pharmacists engage in research. This is likely due to lack of exposure to research during pharmacy school; unlike medical schools, research is not mandatory component of the pharmacy curriculum. The proposed project will expose and engage minority pharmacy students to meritorious research and thereby promote their ability and desire to choose a health disparities research orientated career. Engagement of pharmacists in health disparities research is important because as the most accessible and one of the most trusted health care professionals pharmacists can make a significant impact in local communities, and in particular minority populations. Often, they serve as the initial health care educators, screeners, consultants, and gatekeepers to the community, referring self-managing and self-medicating patients to physicians. By enrolling in a PharmD program CNUCOP students have already demonstrated a commitment to a career in biomedical and behavioral science; exposure and engagement in the proposed research study will stimulate them to consider further specializing in health disparities research. The use of patient specimens and data will help students realize the importance of health disparities research. Mechanistic studies will challenge them to think of ways in which health disparities can be addressed. Active mentorship from the PI will further stimulate them to consider a career in health disparities research.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2021 ( Subtotal = -$94,378 )
2021	2016	CALIFORNIA NORTHSTATE UNIVERSITY, LLC	9700 W TARON DR	ELK GROVE	CA	95757	SACRAMENTO	USA	Cancer Detection and Diagnosis Research	000	1	12/21/2020	NEW	$0
2021	2016	CALIFORNIA NORTHSTATE UNIVERSITY, LLC	9700 W TARON DR	ELK GROVE	CA	95757	SACRAMENTO	USA	Cancer Detection and Diagnosis Research	001	1	7/29/2021	NEW	-$94,378
														Subtotal = -$94,378

Issue Date FY: 2020 ( Subtotal = $0 )
2020	2016	CALIFORNIA NORTHSTATE UNIVERSITY, LLC	9700 W TARON DR	ELK GROVE	CA	95757	SACRAMENTO	USA	Cancer Detection and Diagnosis Research	000	1	2/26/2020	NEW	$0
														Subtotal = $0

Issue Date FY: 2016 ( Subtotal = $421,195 )
2016	2016	CALIFORNIA NORTHSTATE UNIVERSITY, LLC	9700 W TARON DR	ELK GROVE	CA	95757	SACRAMENTO	USA	Cancer Detection and Diagnosis Research	000	1	6/13/2016	NEW	$421,195
														Subtotal = $421,195

Grand Total All Awards = $326,817

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of the AR-ErbB3-Nrdp1 axis in mediating prostate cancer health disparities

Award Number: R15CA202757

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2016

PERIOD OF PERFORMANCE END DATE: 03/31/2021

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer